Summary
Recently, Ciphergen Biosystems (Fremont, CA, USA) has developed a technique called surface-enhanced laser desorption/ionization (SELDI). This technology is based on ProteinChips® with chemically or biochemically modified surfaces for the selective retention and enrichment of protein subsets from a complex protein mixture. The proteins or peptides of interest can then be identified by using mass spectrometry (SELDI-MS). This highly sensitive and high-throughput technique can detect minute differences in proteins and peptide profiles between biological samples. The versatility of this technology enables a wide variety of applications in basic research, clinical, proteomic, and drug discovery such as identification of novel biomarkers associated with certain diseases or treatments. Many disease biomarkers or biomarker patterns have been identified using SELDI-MS in various laboratories. In this chapter, we provide a general guide to the profiling of proteins or peptides as well as biomarker discovery using the most common body fluids such as serum/plasma, nipple aspiration fluid, and urine.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Engwegen, J. Y., Gast, M. C., Schellens, J. H., and Beijnen, J. H. Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry. Trends Pharmacol Sci, 27: 251–259, 2006.
Simpkins, F., Czechowicz, J. A., Liotta, L., and Kohn, E. C. SELDI-TOF mass spectrometry for cancer biomarker discovery and serum proteomic diagnostics. Pharmacogenomics, 6: 647–653, 2005.
Austen, B. M., Frears, E. R., and Davies, H. The use of seldi proteinchip arrays to monitor production of Alzheimer’s betaamyloid in transfected cells. J Pept Sci, 6: 459–469, 2000.
Banks, R. E., Stanley, A. J., Cairns, D. A., Barrett, J. H., Clarke, P., Thompson, D., and Selby, P. J. Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry. Clin Chem, 51: 1637–1649, 2005.
Hortin, G. L. The maldi-tof mass spectrometric view of the plasma proteome and peptidome. Clin Chem, 52: 1223–1237, 2006.
Li, J., Zhao, J., Yu, X., Lange, J., Kuerer, H., Krishnamurthy, S., Schilling, E., Khan, S. A., Sukumar, S., and Chan, D. W. Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid. Clin Cancer Res, 11: 8312–8320, 2005.
Alexander, H., Stegner, A. L., Wagner-Mann, C., Du Bois, G. C., Alexander, S., and Sauter, E. R. Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid. Clin Cancer Res, 10: 7500–7510, 2004.
de Jong, P. E. and Gansevoort, R. T. Screening techniques for detecting chronic kidney disease. Curr Opin Nephrol Hypertens, 14: 567–572, 2005.
Mathieson, P. W. The cellular basis of albuminuria. Clin Sci (Lond), 107: 533–538, 2004.
Ruzhanskaya, A. V., Milenina, O. E., Kravtsov, E. G., Dalin, M. V., and Gabrielyan, N. I. Methodological approaches to detection of Tamm-Horsfall protein. Bull Exp Biol Med, 140: 330–333, 2005.
Simerville, J. A., Maxted, W. C., and Pahira, J. J. Urinalysis: A comprehensive review. Am Fam Physician, 71: 1153–1162, 2005.
Traum, A. Z., Wells, M. P., Aivado, M., Libermann, T. A., Ramoni, M. F., and Schachter, A. D. SELDI-TOF MS of quadruplicate urine and serum samples to evaluate changes related to storage conditions. Proteomics, 6: 1676–1680, 2006.
Sauter, E. R., Shan, S., Hewett, J. E., Speckman, P., and Du Bois, G. C. Proteomic analysis of nipple aspirate fluid using SELDI-TOF-MS. Int J Cancer, 114: 791–796, 2005.
Ruetschi, U., Rosen, A., Karlsson, G., Zetterberg, H., Rymo, L., Hagberg, H., and Jacobsson, B. Proteomic analysis using protein chips to detect biomarkers in cervical and amniotic fluid in women with intra-amniotic inflammation. J Proteome Res, 4: 2236–2242, 2005.
Streckfus, C. F. and Bigler, L. R. Saliva as a diagnostic fluid. Oral Dis, 8: 69–76, 2002.
Lawrence, H. P. Salivary markers of systemic disease: noninvasive diagnosis of disease and monitoring of general health. J Can Dent Assoc, 68: 170–174, 2002.
Kaufman, E. and Lamster, I. B. The diagnostic applications of saliva–a review. Crit Rev Oral Biol Med, 13: 197–212, 2002.
Streckfus, C. F., Bigler, L. R., and Zwick, M. The use of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to detect putative breast cancer markers in saliva: A feasibility study. J Oral Pathol Med, 35: 292–300, 2006.
Thompson, E. J. Quality versus quantity: Which is better for cerebrospinal fluid IgG? Clin Chem , 50: 1721–1722, 2004.
Romeo, M. J., Espin a, V., Lowenthal, M., Espina, B. H., Petricoin, E. F., 3rd, and Liotta, L. A. CSF proteome: A protein repository for potential biomarker identification. Expert Rev Proteomics, 2: 57–70, 2005.
Guerreiro, N., Gomez-Mancilla, B., and Charmont, S. Optimization and evaluation of surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry for protein profiling of cerebrospinal fluid. Proteome Sci, 4: 7, 2006.
Richter, R., Schulz-Knappe, P., Schrader, M., Standker, L., Jurgens, M., Tammen, H., and Forssmann, W. G. Composition of the peptide fraction in human blood plasma: database of circulating human peptides. J Chromatogr B Biomed Sci Appl, 726: 25–35, 1999.
Kong, F., Nicole White, C., Xiao, X., Feng, Y., Xu, C., He, D., Zhang, Z., and Yu, Y. Using proteomic approaches to identify new biomarkers for detection and monitoring of ovarian cancer. Gynecol Oncol, 100: 247–253, 2006.
Ye, B., Cramer, D. W., Skates, S. J., Gygi, S. P., Pratomo, V., Fu, L., Horick, N. K., Licklider, L. J., Schorge, J. O., Berkowitz, R. S., and Mok, S. C. Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry. Clin Cancer Res, 9: 2904–2911, 2003.
Voshol, H., Brendlen, N., Muller, D., Inverardi, B., Augustin, A., Pally, C., Wieczorek, G., Morris, R. E., Raulf, F., and van Oostrum, J. Evaluation of biomarker discovery approaches to detect protein biomarkers of acute renal allograft rejection. J Proteome Res, 4: 1192–1199, 2005.
de Seny, D., Fillet, M., Meuwis, M. A., Geurts, P., Lutteri, L., Ribbens, C., Bours, V., Wehenkel, L., Piette, J., Malaise, M., and Merville, M. P. Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach. Arthritis Rheum, 52: 3801–3812, 2005.
Yang, S. Y., Xiao, X. Y., Zhang, W. G., Zhang, L. J., Zhang, W., Zhou, B., Chen, G., and He, D. C. Application of serum SELDI proteomic patterns in diagnosis of lung cancer. BMC Cancer, 5: 83, 2005.
Zhang, H., Kong, B., Qu, X., Jia, L., Deng, B., and Yang, Q. Biomarker discovery for ovarian cancer using SELDI-TOF-MS. Gynecol Oncol, 102: 61–66, 2006.
Murphy, V. E., Johnson, R. F., Wang, Y. C., Akinsanya, K., Gibson, P. G., Smith, R., and Clifton, V. L. The effect of maternal asthma on placental and cord blood protein profiles. J Soc Gynecol Investig, 12: 349–355, 2005.
Zhang, Y. F., Wu, D. L., Guan, M., Liu, W. W., Wu, Z., Chen, Y. M., Zhang, W. Z., and Lu, Y. Tree analysis of mass spectral urine profiles discriminates transitional cell carcinoma of the bladder from noncancer patient. Clin Biochem, 37: 772–779, 2004.
Clarke, W., Silverman, B. C., Zhang, Z., Chan, D. W., Klein, A. S., and Molmenti, E. P. Characterization of renal allograft rejection by urinary proteomic analysis. Ann Surg, 237: 660–664; discussion 664–665, 2003.
Schaub, S., Wilkins, J., Weiler, T., Sangster, K., Rush, D., and Nickerson, P. Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry. Kidney Int, 65: 323–332, 2004.
Kemna, E., Tjalsma, H., Laarakkers, C., Nemeth, E., Willems, H., and Swinkels, D. Novel urine hepcidin assay by mass spectrometry. Blood, 106: 3268–3270, 2005.
Dare, T. O., Davies, H. A., Turton, J. A., Lomas, L., Williams, T. C., and York, M. J. Application of surface-enhanced laser desorption/ionization technology to the detection and identification of urinary parvalbumin-alpha: a biomarker of compound-induced skeletal muscle toxicity in the rat. Electrophoresis, 23: 3241–3251, 2002.
Ye, B., Skates, S., Mok, S. C., Horick, N. K., Rosenberg, H. F., Vitonis, A., Edwards, D., Sluss, P., Han, W. K., Berkowitz, R. S., and Cramer, D. W. Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine. Clin Cancer Res, 12: 432–441, 2006.
Acknowledgments
Financial support from the NIH Cancer Institute (R21 CA11949-01) is acknowledged. We also acknowledge Drs. Daniel Cramer, Samuel Mok and Brian Liu from Brigham and Women’s Hospital and Dr. Miron Alexander from Dana-Farber cancer Institute for their encouraging discussion during the manuscript preparation.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Gagnon, A., Shi, Q., Ye, B. (2008). Surface-Enhanced Laser Desorption/Ionization Mass Spectrometry for Protein and Peptide Profiling of Body Fluids. In: Liu, B.CS., Ehrlich, J.R. (eds) Tissue Proteomics. Methods in Molecular Biology™, vol 441. Humana Press. https://doi.org/10.1007/978-1-60327-047-2_3
Download citation
DOI: https://doi.org/10.1007/978-1-60327-047-2_3
Publisher Name: Humana Press
Print ISBN: 978-1-58829-679-5
Online ISBN: 978-1-60327-047-2
eBook Packages: Springer Protocols